YUDELKIS JIMENEZ DELGADO: Open Payments
NPI 1386360535 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 28 payments from 9 companies in 2025. Trend: 2023 $687 · 2024 $1,092 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $201 |
| SCPHARMACEUTICALS INC. | 6 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| Amgen Inc. | 3 | $66 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $53 |
| PFIZER INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VERQUVO, FUROSCIX, Kerendia, Repatha, LifeVest, CAPVAXIVE, LEQVIO, FARXIGA.
Industry payments across FL — which companies pay providers there.
